Production (Stage)

Research & News

With inflation likely peaking, investors are hopeful the Fed will slow its aggressive rate hike campaign.
Strategic Options Subscription
Bulls could not get anything going early Tuesday, and the lethargy was their undoing. The S&P 500 careened through important support levels on the way to 3,941, a closing loss of 1.4%. It was...
Strategic Options Subscription Alert
Stocks are sinking again following woeful warnings from bank chiefs at a time when concerns about the impacts of Federal Reserve policy on growth and corporate earnings are acute.
Resource Trader Subscription Alert
Most traders are starting to price in another leg down.
Weiss Investor Signals Subscription Your Issue
A healthy dose of drug stocks has turned out to be a great investment prescription.
In this segment, Investment Analyst Nilus Mattive discusses strategies like tax-loss harvesting to help you these last few weeks of 2022.
Strategic Options Subscription
In 2022, investors have contended with a messy war in Eastern Europe, worldwide inflation and supply chain bottlenecks. It’s been a tough slog, yet there are better times ahead. The world is...
While this week might not be as exciting as last, we’ve got one very important piece of economic data on Friday.
Strategic Options Subscription Alert
Stocks are kicking off the week with losses and bond yields climbed as a U.S. services gauge rose unexpectedly.
Safe Money Report Subscription Your Issue
This week, I have the pleasure of sitting down with Kenny Polcari, host of Wealth & Wisdom, who interviews those in the know.
Top Tech Stocks
See All »
B
NVDA NASDAQ $173.50
B
MSFT NASDAQ $513.71
B
ORCL NYSE $245.12
Top Consumer Staple Stocks
See All »
Top Financial Stocks
See All »
B
B
JPM NYSE $298.62
B
V NYSE $357.04
Top Energy Stocks
See All »
B
ENB.TO TSX $60.97
B
ENB NYSE $44.97
Top Health Care Stocks
See All »
B
ABT NYSE $126.54
B
SYK NYSE $403.53
B
MCK NYSE $711.82
Top Real Estate Stocks
See All »
B
WELL NYSE $161.56
B